Skip to main content
Year archive

Sinco Pharmaceuticals Holdings Limited — 2018 filings

All 112 regulatory filings released by Sinco Pharmaceuticals Holdings Limited (6833) in 2018, sourced directly from the official regulator.

112 Filings
2018 Period
2018 filings (112)
Filing Released Lang
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2018-12-31 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2018-12-27 English
Terms of Reference for the Audit Committee
Governance Information
2018-12-24 English
INSIDE INFORMATION ADOPTION OF DIVIDEND POLICY
Notice of Dividend Amount
2018-12-21 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2018-12-20 English
VOLUNTARY ANNOUNCEMENT MEMORANDUM OF UNDERSTANDING IN RESPECT OF A POSSIBLE ACQUISITION
M&A Activity
2018-12-16 English
VOLUNTARY ANNOUNCEMENT - PARECOXIB SODIUM FOR INJECTION OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2018-12-10 English
NEXT DAY DISCLOSURE RETURN
Share Issue/Capital Change
2018-12-07 English
VOLUNTARY ANNOUNCEMENT - UNUSUAL PRICE AND TRADING VOLUME MOVEMENTS AND RESULTS OF CENTRALISED MEDICINES PROCUREMENT
Regulatory Filings
2018-12-06 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2018
Share Issue/Capital Change
2018-12-03 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2018
Share Issue/Capital Change
2018-12-03 English
VOLUNTARY ANNOUNCEMENT - PARECOXIB SODIUM FOR INJECTION OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2018-11-29 English
THIRD QUARTERLY RESULTS ANNOUNCEMENT FOR THE NINE MONTHS ENDED 30 SEPTEMBER, 2018
Interim / Quarterly Report
2018-11-22 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2018-11-08 English
(1) RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CO-CHIEF EXECUTIVE OFFICER&#x3b; (2) APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR&#x3b; AND (3) CHANGE OF COMPOSITION OF BOARD COMMIT
Board/Management Information
2018-11-08 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2018
Capital/Financing Update
2018-11-02 English
NOTIFICATION OF BOARD MEETING
Regulatory Filings
2018-11-01 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2018
Capital/Financing Update
2018-11-01 English
VOLUNTARY ANNOUNCEMENT - MOXIFLOXACIN HYDROCHLORIDE AND SODIUM CHLORIDE INJECTION OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2018-10-31 English
VOLUNTARY ANNOUNCEMENT - BORTEZOMIB FOR INJECTION OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2018-10-12 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2018
Share Issue/Capital Change
2018-10-04 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2018
Capital/Financing Update
2018-10-02 English
2018 Interim Report
Interim / Quarterly Report
2018-09-18 English
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
Transaction in Own Shares
2018-09-13 English
2018 INTERIM REPORT
Interim / Quarterly Report
2018-09-13 English
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
Transaction in Own Shares
2018-09-12 English
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
Transaction in Own Shares
2018-09-11 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2018
Share Issue/Capital Change
2018-09-04 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2018
Share Issue/Capital Change
2018-09-03 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2018
Interim / Quarterly Report
2018-08-30 English
CHANGE OF JOINT COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE
Board/Management Information
2018-08-30 English
VOLUNTARY ANNOUNCEMENT - DECLARATION MADE FOR DABIGATRAN ETEXILATE CAPSULES
Regulatory Filings
2018-08-23 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE, 2018
Interim / Quarterly Report
2018-08-22 English
DATE OF BOARD MEETING
Report Publication Announcement
2018-08-20 English
VOLUNTARY ANNOUNCEMENT - DECLARATION MADE FOR POMALIDOMIDE CAPSULES
Regulatory Filings
2018-08-16 English
VOLUNTARY ANNOUNCEMENT - COMMENCEMENT OF PHASE I CLINICAL TRIAL OF PERTUZUMAB SOLUTION FOR INJECTION
Regulatory Filings
2018-08-08 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2018
Share Issue/Capital Change
2018-08-06 English
VOLUNTARY ANNOUNCEMENT - PASSING OF EU GMP CERTIFICATION FOR TENOFOVIR PRODUCTION LINE
Regulatory Filings
2018-08-01 English
NOTIFICATION OF BOARD MEETING
Regulatory Filings
2018-08-01 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2018
Regulatory Filings
2018-08-01 English
2017 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
Environmental & Social Information
2018-07-23 English
VOLUNTARY ANNOUNCEMENT BORTEZOMIB FOR INJECTION OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2018-07-20 English
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
Transaction in Own Shares
2018-07-05 English
VOLUNTARY ANNOUNCEMENT IODIXANOL INJECTION OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2018-07-03 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2018
Share Issue/Capital Change
2018-07-03 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2018
Share Issue/Capital Change
2018-07-03 English
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
Transaction in Own Shares
2018-06-27 English
VOLUNTARY ANNOUNCEMENT DOCETAXEL INJECTION OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2018-06-27 English
VOLUNTARY ANNOUNCEMENT LIDOCAINE CATAPLASM OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2018-06-19 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2018-06-19 English
VOLUNTARY ANNOUNCEMENT "CALCIUM LEVOFOLINATE FOR INJECTION" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2018-06-07 English
INSIDE INFORMATION LAPSE OF MEMORANDUM OF UNDERSTANDING RELATING TO A POSSIBLE ACQUISITION
M&A Activity
2018-06-06 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2018
Regulatory Filings
2018-06-04 English
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
Transaction in Own Shares
2018-06-01 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2018
Capital/Financing Update
2018-06-01 English
ISSUE OF CONVERTIBLE BONDS UNDER SPECIFIC MANDATE: TERMINATION OF AMENDED AND RESTATED SUBSCRIPTION AGREEMENT
Capital/Financing Update
2018-05-29 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 29 MAY 2018
Declaration of Voting Results & Voting Rights Announcements
2018-05-29 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2018-05-25 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 25 MAY 2018 AND RETIREMENT OF DIRECTORS
Declaration of Voting Results & Voting Rights Announcements
2018-05-25 English
"ENTECAVIR DISPERSIBLE TABLET" PASSES CONSISTENCY EVALUATION
Regulatory Filings
2018-05-23 English
FIRST QUARTERLY RESULTS ANNOUNCEMENT FOR THE THREE MONTHS ENDED 31 MARCH, 2018
Interim / Quarterly Report
2018-05-18 English
VOLUNTARY ANNOUNCEMENT - "ANLOTINIB HYDROCHLORIDE CAPSULES" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2018-05-10 English
NOTIFICATION OF BOARD MEETING
Regulatory Filings
2018-05-07 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2018
Regulatory Filings
2018-05-07 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2018
Regulatory Filings
2018-05-03 English
VOLUNTARY ANNOUNCEMENT - GANIRELIX ACETATE INJECTION OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2018-05-02 English
VOLUNTARY ANNOUNCEMENT - COMPOUND SODIUM ACETATE RINGER'S INJECTION OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2018-05-02 English
VOLUNTARY ANNOUNCEMENT UPDATE ON ANLOTINIB
Regulatory Filings
2018-04-27 English
VOLUNTARY ANNOUNCEMENT SUCCESSFUL INCLUSION OF SIX PRODUCTS OF THE GROUP INTO JIANGSU MEDICAL INSURANCE CATALOGUE
Regulatory Filings
2018-04-26 English
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING (OR ANY ADJOURNMENT THEREOF)
AGM Information
2018-04-25 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2018-04-25 English
GENERAL MANDATES TO ISSUE AND BUY BACK SHARES, RE-ELECTION OF DIRECTORS, BONUS ISSUE OF SHARES, AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2018-04-25 English
2017 ANNUAL REPORT
Regulatory Filings
2018-04-25 English
(I) DISCLOSURE UNDER RULE 13.17 OF THE LISTING RULES&#x3b; AND (II) UPDATE ON ISSUE OF CONVERTIBLE BONDS UNDER SPECIFIC MANDATE
Capital/Financing Update
2018-04-23 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement
2018-04-23 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2018-04-23 English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2018-04-23 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2018-04-23 English
Annual Report 2017
Annual Report
2018-04-23 English
PROPOSED BONUS ISSUE OF SHARES
Share Issue/Capital Change
2018-04-17 English
VOLUNTARY ANNOUNCEMENT - COMMENCEMENT OF PHASE I CLINICAL TRIAL OF "ANTI-PD-L1 HUMANIZED MONOCLONAL ANTIBODY" INJECTION
Regulatory Filings
2018-04-10 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2018
Capital/Financing Update
2018-04-09 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2018
Capital/Financing Update
2018-04-09 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2017
Annual Report
2018-03-29 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR "YILUNPING"
Regulatory Filings
2018-03-28 English
FURTHER AMENDMENTS TO THE BONDS ISSUED IN JUNE 2017
Capital/Financing Update
2018-03-27 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER, 2017
Annual Report
2018-03-22 English
DATE OF BOARD MEETING
Regulatory Filings
2018-03-19 English
INSIDE INFORMATION STRATEGIC COOPERATION AGREEMENT
Capital/Financing Update
2018-03-18 English
INSIDE INFORMATION MEMORANDUM OF UNDERSTANDING RELATING TO A POSSIBLE ACQUISITION
M&A Activity
2018-03-06 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 28 February 2018
Share Issue/Capital Change
2018-03-05 English
PROFIT WARNING
Regulatory Filings
2018-03-02 English
COMPLETION OF (1) MAJOR AND CONNECTED TRANSACTION&#x3b; (2) ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE&#x3b; AND (3) APPLICATION FOR WHITEWASH WAIVER
Capital/Financing Update
2018-03-01 English
NOTIFICATION OF BOARD MEETING
Regulatory Filings
2018-03-01 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2018-03-01 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 28 February 2018
Share Issue/Capital Change
2018-03-01 English
(1) MAJOR AND CONNECTED TRANSACTION&#x3b; (2) ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE&#x3b; AND (3) APPLICATION FOR WHITEWASH WAIVER POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING
Declaration of Voting Results & Voting Rights Announcements
2018-02-12 English
VOLUNTARY ANNOUNCEMENT PROGRESS OF DRUG REGISTRATION APPLICATION
Regulatory Filings
2018-02-06 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2018
Share Issue/Capital Change
2018-02-06 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2018
Regulatory Filings
2018-02-01 English
DESPATCH OF CIRCULAR IN RELATION TO (1) MAJOR AND CONNECTED TRANSACTION&#x3b; (2) ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE&#x3b; (3) APPLICATION FOR WHITEWASH WAIVER&#x3b; AND (4) NOT
Regulatory Filings
2018-01-26 English
PROXY FORM FOR USE AT THE EXTRAORDINARY GENERAL MEETING (THE "EGM") TO BE HELD ON MONDAY, 12 FEBRUARY 2018 (OR ANY ADJOURNMENT THEREOF)
Proxy Solicitation & Information Statement
2018-01-26 English
NOTICE OF EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement
2018-01-26 English
(1) MAJOR AND CONNECTED TRANSACTION&#x3b; (2) ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE&#x3b; AND (3) APPLICATION FOR WHITEWASH WAIVER
Proxy Solicitation & Information Statement
2018-01-26 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2018-01-19 English
APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTORS
Board/Management Information
2018-01-19 English
(I) AMENDMENTS TO THE TERMS AND CONDITIONS OF THE CONVERTIBLE BONDS ISSUED IN JUNE 2017 (II) COMPLETION OF FIRST TRANCHE OF FIRST PART CB (III) CONVERSION OF FIRST TRANCHE OF FIRST PART CB
Capital/Financing Update
2018-01-17 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR "TUOTUO"
Regulatory Filings
2018-01-10 English
(1) MAJOR AND CONNECTED TRANSACTION&#x3b; (2) ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE&#x3b; AND (3) APPLICATION FOR WHITEWASH WAIVER
Capital/Financing Update
2018-01-05 English
ADOPTION OF RESTRICTED SHARE AWARD SCHEME
Regulatory Filings
2018-01-05 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2017
Share Issue/Capital Change
2018-01-05 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2017
Regulatory Filings
2018-01-02 English